Nifty 50 Ended Over 1% Higher; Wholesale Inflation Rose To 8.3% YoY
- Share.Market
- 11 min read
- 14 May 2026
Here’s a quick wrap-up where we break down the performance of key indices, top corporate movers, and the major economic headlines of the day.
Bouncing back from recent declines, Nifty 50 and Sensex ended over 1% higher on Thursday, May 14. This momentum was driven by ongoing US-China talks and expectations that these meetings would help resolve the US-Iran dispute. Furthermore, most sectoral indices closed in the green today, with Nifty Pharma emerging as the top leader.
Key Indices – Share Market
Today’s Top News from the Indian Share Market
MTARTECHMTAR Technologies received blanket purchase orders worth $238.76 million (₹2,278.96 crore). The contract was awarded by an undisclosed existing international customer for regular business operations and does not fall under related-party transactions.
ZYDUSLIFEZydus Lifesciences’ subsidiary signed an agreement to acquire US-based Assertio Holdings for approximately $166.4 million. The acquisition, priced at $23.50 per share, provides Zydus with an immediate speciality oncology footprint in the US, leveraging Assertio’s existing commercial infrastructure.
BHARTIARTLBharti Airtel reported FY26 results with total consolidated revenues rising 15.7% year-on-year to ₹55,383 crore. The company’s customer base reached 666 million across 15 countries, while EBITDA grew 16.9% to ₹32,038 crore, yielding a net income of ₹7,245 crore.
APLLTDAlembic Pharmaceuticals received tentative USFDA approval for its 300 mg Darolutamide Tablets, used for treating prostate cancer. The drug, therapeutically equivalent to Bayer’s Nubeqa, targets an estimated market size of $3,155 million, bringing Alembic’s total ANDA approvals to 238.
OILOil India declared FY26 results, achieving a 62% year-on-year jump in its Q4 FY26 consolidated PAT to ₹2,424 crore. The company reported its highest drilling operations during the year, and also recommended a final dividend of ₹1 per share.
CROMPTONCrompton Greaves reported an 11% year-on-year revenue increase to ₹2,283 crore for Q4 FY26. However, the company posted a net loss of ₹531 crore for the quarter, primarily driven by a ₹716 crore exceptional impairment charge on its Butterfly Gandhimathi investment.
Broader Market Performance Today
INDIA VIXTop Performing Sectors Today
*Prices shown may have delay up-to 15 minutes
Today’s Top Gainers and Losers
*Prices shown may have delay up-to 15 minutes
FII DII Activity (₹ Cr)
| Date | FII (Net Value) | DII (Net Value) |
| 13 May 2026 | -4,703.15 | 5,869.05 |
| 12 May 2026 | -1,959.39 | 7,990.32 |
| 11 May 2026 | -8,437.56 | 5,939.65 |
| 08 May 2026 | -4,110.60 | 6,748.13 |
| 07 May 2026 | -340.89 | 441.07 |
| Month-to-Date | -26,172.45 | 41,191.87 |
What’s Happening Beyond Markets?
- India’s wholesale inflation surged to 8.3% year-on-year in April 2026. This positive rate was primarily driven by a sharp 24.71% rise in fuel and power inflation, alongside increases in crude petroleum, natural gas, and basic metals.
- A landmark tripartite MoU was signed to develop India’s first Mega Greenfield Shipyard in Thoothukudi. With a 2.5 million GT capacity, this Indo-Korean partnership is expected to generate approximately 15,000 direct jobs upon operational stabilisation.
- The Cabinet has approved increased Minimum Support Prices for 14 Kharif crops for the 2026-27 marketing season. Sunflower Seed saw the highest absolute increase of ₹622 per quintal, aiming to ensure remunerative prices for farmers.
- The Technology Development Board is backing Helix Cell Therapeutics to develop an advanced, dual-targeting CAR-T cell therapy for Multiple Myeloma. This Indo-Singapore collaboration aims to conduct Phase I clinical trials for this currently incurable blood cancer.
- As per SIAM data, passenger vehicle sales reached a record high of 4.37 lakh units in April. Additionally, total vehicle production across categories remained robust, hitting 29.22 lakh units for the month.
Result Update
Track who beat or missed street estimates from the Nifty50
| Stock | Revenue from Operations FY26 (Estimated) | Revenue from Operations FY26 (Actual) | Change |
| Dr. Reddy’s Laboratories Ltd. | 34,337.82 | 33,593.3 | 🔻 2.17% |
| Dixon Technologies (India) Ltd. | 48,961.35 | 48,872.80 | 🔻 0.18% |
| Berger Paints (India) Ltd. | 11,873.36 | 11,880.25 | 🔼 0.06% |
IPO Categories Explained: Qualified Institutional Buyers (QIB)
Back to Basics
Terms that put you one step ahead – every day
What are Weighted Average Shares?
In corporate finance, “weighted average shares” is a calculation that accounts for changes in a company’s total number of outstanding shares over a specific period. Think of it like splitting profits at a startup. If you start the year with 10 equal partners, but bring in 2 more exactly halfway through, dividing the year’s total profits by 12 wouldn’t be fair to the founders. You’d calculate an average based on how long those new partners were actually there (effectively 11 shares for the year).
Public companies constantly issue new stock or buy back existing shares. For everyday investors, this number is vital. It’s the exact figure used to calculate Earnings Per Share (EPS). By weighting shares based on time, investors get an accurate, unskewed picture of a company’s true profitability per share.
Learn more: https://www.share.market/buzz/stocks/weighted-average-shares/
Before You Go…
Markets aren’t just charts and tickers; they’re daily tales of ambition and the quiet courage to stay invested.
We’ll be back to cut through the noise, so you can focus on investing intelligently.
